Clarithromycin (Biaxin) Risky In Patients With Heart Disease
The National Agency for Food and Drug Administration and Control (NAFDAC) is sharing an alert that was sent out by the United States Food and Drug Administration (USFDA) that Clarithromycin (Biaxin) is risky in patients with heart disease. Heart disease patients who take the drug, sold under the brand name Biaxin, can die years later. […]
Yobe State Governor Donates Offices And Land To Nafdac
, In his concerted efforts to combat the rising incidence of drug abuse and support the fight against counterfeit drugs and other substandard regulated products, Yobe State governor, Alhaji Ibrahim Gaidam has donated two office complexes and a large parcel of land to the National Agency for Food and Drug Administration and Control, NAFDAC […]
